StockData
CURLFOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

Curaleaf Holdings, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$7.63−0.20 (-2.55%)

Close on Oct 19, 2026

Market cap
$2.07B
P/E (TTM)
–
Dividend yield
–

Curaleaf Holdings, Inc. revenue by segment

By business segment

RevenueFY2025FY2024FY2023FY2022FY2021FY2020FY2019% of revenueYoY
Domestic$1.10B$1.23B$1.29B$1.24B$1.18B––86.4%-10.8%
International$172.48M$105.55M$61.01M$34.43M$18.77M––13.6%+63.4%
Cannabis––––$1.19B$586.22M$173.86M––
Non-Cannabis––––$2.32M$40.42M$47.16M––
Operating incomeFY2025FY2024FY2023FY2022FY2021FY2020FY2019YoY
Domestic$34.10M$49.39M$71.73M––––-31.0%
International-$8.65M-$24.64M-$28.85M––––-64.9%
Cannabis––––$249.25M$130.95M-$6.35M–
Non-Cannabis––––-$83.26M-$58.51M-$21.37M–

By product or service

RevenueFY2025FY2024FY2023FY2022FY2021FY2020FY2019% of revenueYoY
Retail and wholesale revenues$1.25B$1.33B$1.34B$1.27B$1.19B––99.0%-5.5%
Retail revenues$922.58M$1.03B$1.10B$1.00B$859.96M––72.8%-10.7%
Wholesale revenues$332.24M$295.57M–––––26.2%+12.4%
Management fee income$13.31M$5.97M$5.85M$4.84M$2.32M––1.0%+123.1%
Wholesale revenues–$303.94M$243.61M$269.04M$333.71M––––
Other–––$4.84M$2.32M––––

By region

From the segment and revenue-disaggregation notes of Curaleaf's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.